Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Bistos Co. Ltd. (419540:KRX), powered by AI.
Bistos Co. Ltd. is currently trading at ₩3,200. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Bistos Co. Ltd. on Alpha Lenz.
Bistos Co. Ltd.'s P/E ratio is -21.0.
“Bistos Co. Ltd. trades at a P/E of -21.0 (undervalued) with modest ROE of -3.7%.”
Ask for details →Bistos Co. Ltd. is a prominent player in the medical equipment manufacturing industry, focusing on innovative solutions for healthcare needs. The primary function of Bistos is to develop, produce, and supply advanced medical devices that enhance patient care quality and efficiency. Notably, the company specializes in diagnostic and monitoring devices, such as fetal and patient monitors, ultrasound systems, and therapeutic equipment. These products serve critical roles in hospitals, clinics, and healthcare facilities, providing essential diagnostics and real-time monitoring that support medical professionals in delivering effective care. Bistos Co. Ltd. plays a significant role in the healthcare sector by addressing the growing demand for technologically advanced medical tools. Its commitment to research and development ensures that the products not only meet current healthcare standards but also pave the way for future innovations. Operating in a vital industry, Bistos contributes to improving healthcare outcomes globally, making it a key component of the medical technology market. Established in South Korea, the company continues to leverage its expertise and advanced manufacturing capabilities to sustain its position as a trusted brand in medical equipment worldwide.
“Bistos Co. Ltd. trades at a P/E of -21.0 (undervalued) with modest ROE of -3.7%.”
Ask for details →Bistos Co. Ltd. (ticker: 419540) is a company listed on KRX in the Common Stock sector (Common Stock). Market cap is $14.7B.
The current price is ₩3,200 with a P/E ratio of -21.05x and P/B of 0.82x.
ROE is -3.75% and operating margin is -6.41%. Annual revenue is $17.1B.